Hypericum perforatum (English Wikipedia)

WHO (2002). WHO Monographs on Selected Medicinal Plants 2: 2002 – V, 357 S.: graph. Darst. Geneva, Switzerland: World Health Organization. pp. 149–165. ISBN 9241545372. Retrieved 28 July 2023.
Gillett JM (1981). The St. John's-Worts of Canada (Guttiferae). Ottawa, Canada: National Museums of Canada, National Museum of Natural Sciences. pp. 25–26. ISBN 978-0-660-10323-5.
Winston R, Randall CB, Schwarzländer M, Reardon R (2010). Biology and Biological Control of Common St. Johnswort. Morgantown, West Virginia: U.S. Dept. of Agriculture, Forest Service, FHTET. Retrieved 2 August 2023.
Fritsch FE, Salisbury EJ (1920). An Introduction to the Structure and Reproduction of Plants. London: G. Bell and Sons Ltd. p. 151.
Stace CA (2010). New Flora of the British Isles (Third ed.). Cambridge, U.K.: Cambridge University Press. p. 339. ISBN 978-0-521-70772-5.
Trickey-Bapty C (2001). Martyrs and miracles. New York: Testament Books. p. 132. ISBN 9780517164037. Retrieved 26 July 2023.
Grigson G (1960). The Englishman's Flora (2nd ed.). London: Phoenix House Ltd. pp. 75–79. Retrieved 10 August 2023.
Cecil E (1896). A history of Gardening in England. London: Bernard Quaritch. pp. 71–72. Retrieved 26 July 2023.
Charles Vancouver Piper, Rolla Kent Beattie (1915). Flora of the Northwest Coast. Press of the New era printing Company. p. 240.
Harris P, Peschkin DP (1974). "Biologcal Control of St. Johns-Wort". Canada Agriculture. 19 (1). Ottawa, Canada: Canada Department of Agriculture: 13–15.
Copping L, ed. (2004). The manual of biocontrol agents: a world compendium (Third ed.). Alton, Hampshire, United Kingdom: British Crop Protection Council. pp. 270–271. ISBN 1-901396-35-5. Retrieved 2 August 2023.
Shield R (1856). Practical Hints Respecting Moths and Butterflies, With Notices of Their Localities : Forming a Calendar of Entomological Operations Throughout the Year, in Pursuit of Lepidoptera. London: John Van Voorst. pp. 7, 42, 59, 83, 101. Retrieved 10 August 2023.

berkeley.edu

ucjeps.berkeley.edu

"Hypericum perforatum subsp. perforatum". The Jepson Herbarium. University of California, Berkeley. 2023. Retrieved 29 July 2023.

biodiversitylibrary.org

Robson N (2002). "Studies in the genus Hypericum L. (Guttiferae) 4(2). Section 9. Hypericum sensu lato (part 2): subsection 1. Hypericum series 1. Hypericum". Bulletin of the British Museum (Natural History) Botany. 32: 61–123 – via Biodiversity Heritage Library.

bladmineerders.nl

"bladmineerders.nl". bladmineerders.nl. Archived from the original on 4 March 2016. Retrieved 18 January 2019.

books.google.com

Ernst E (2003). Hypericum: the genus Hypericum. Medicinal and Aromatic Plants—Industrial Profiles. Vol. 31. London: Taylor & Francis. ISBN 9781420023305.
Comparison of selected chemical constituents of Hypericum perforatum

brandeis.edu

bio.brandeis.edu

Chen SY, Hamer D (2003). "Common St.John's Wort". A Field Guide to Non-Native Species of Eastern Massachusetts. Brandeis University. Retrieved 29 July 2023.

cabi.org

Ian Popay (22 June 2015). "Hypericum perforatum (St John's wort)". CABI. Retrieved 2 December 2018.

cancer.gov

"Questions and Answers About St. John's Wort". National Cancer Institute. 2024. Archived from the original on 2 October 2024.

cancerresearchuk.org

"St John's wort and cancer". Cancer Research UK. 2022. Archived from the original on 12 June 2024.

cancervic.org.au

"Complementary therapies". Cancer Council Victoria. 2024. Archived from the original on 3 October 2024.

colostate.edu

poisonousplants.cvmbs.colostate.edu

"Guide to Poisonous Plants – College of Veterinary Medicine and Biomedical Sciences – Colorado State University". poisonousplants.cvmbs.colostate.edu. Retrieved 23 September 2023.

doi.org

Soelberg J, Jorgensen LB, Jager AK (26 January 2007). "Hyperforin Accumulates in the Translucent Glands of Hypericum perforatum". Annals of Botany. 99 (6): 1097–1100. doi:10.1093/aob/mcm057. PMC 3243575. PMID 17468113.
Ciccarelli D (October 2001). "Translucent Glands and Secretory Canals in Hypericum perforatum L. (Hypericaceae): Morphological, Anatomical and Histochemical Studies During the Course of Ontogenesis" (PDF). Annals of Botany. 88 (4): 637–644. doi:10.1006/ANBO.2001.1514. Retrieved 28 July 2023.
Zobayed SM, Afreen F, Goto E, Kozai T (1 October 2006). "Plant–Environment Interactions: Accumulation of Hypericin in Dark Glands of Hypericum perforatum". Annals of Botany. 98 (4): 793–804. doi:10.1093/aob/mcl169. PMC 2806163. PMID 16891333.
Umek A, Kreft S, Kartnig T, Heydel B (1999). "Quantitative phytochemical analyses of six hypericum species growing in slovenia". Planta Med. 65 (4): 388–90. doi:10.1055/s-2006-960798. PMID 17260265. S2CID 260248637.
Tatsis EC, Boeren S, Exarchou V, Troganis AN, Vervoort J, Gerothanassis IP (2007). "Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS". Phytochemistry. 68 (3): 383–93. Bibcode:2007PChem..68..383T. doi:10.1016/j.phytochem.2006.11.026. PMID 17196625. S2CID 28120366.
Anzenbacher P, Zanger UM, eds. (2012). Metabolism of Drugs and Other Xenobiotics. Weinheim, Germany: Wiley-VCH. doi:10.1002/9783527630905. ISBN 978-3-527-63090-5.
Linné C, Salvius L (1753). Species plantarum. Holmiae: Impensis Laurentii Salvii. p. 785. doi:10.5962/bhl.title.669.
Registry-Migration.Gbif.Org (2022). "Hypericum perforatum L." GBIF Secretariat. Global Biodiversity Information Facility. doi:10.15468/39omei. Retrieved 1 August 2023.
Marcone C, Bellardi M, Bertaccini A (2016). "Phytoplasma diseases of medicinal and aromatic plants". Journal of Plant Pathology. 98 (3): 379–404. doi:10.4454/JPP.V98I3.060. JSTOR 44280481.
Mayor A (1 January 2019), Wexler P (ed.), "Chapter 11 – Mithridates of Pontus and His Universal Antidote", Toxicology in Antiquity (Second Edition), History of Toxicology and Environmental Health, Academic Press, pp. 161–174, doi:10.1016/b978-0-12-815339-0.00011-1, ISBN 978-0-12-815339-0, retrieved 27 September 2023
Karamanou M, Androutsos G (1 January 2019), Wexler P (ed.), "Chapter 12 - Theriaca Magna: The Glorious Cure-All Remedy", Toxicology in Antiquity (Second Edition), History of Toxicology and Environmental Health, Academic Press, pp. 175–184, doi:10.1016/b978-0-12-815339-0.00012-3, ISBN 978-0-12-815339-0, retrieved 27 September 2023
Süntar IP, Akkol EK, Yılmazer D, et al. (2010). "Investigations on the in vivo wound healing potential of Hypericum perforatum L.". Journal of Ethnopharmacology. 127 (2): 468–77. doi:10.1016/j.jep.2009.10.011. PMID 19833187.
Gaid M, Biedermann E, Füller J, et al. (1 May 2018). "Biotechnological production of hyperforin for pharmaceutical formulation". European Journal of Pharmaceutics and Biopharmaceutics. Innovative Processes for Bio-Pharmaceuticals and Poorly Water-Soluble API. 126: 10–26. doi:10.1016/j.ejpb.2017.03.024. ISSN 0939-6411. PMID 28377273. S2CID 4701643.
Linde K, Kriston L, Rücker G, Jamila S, Schumann I, Meissner K, Sigterman K, Schneider A (February 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Annals of Family Medicine. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895.
Linde K, Berner MM, Kriston L (2008). Linde K (ed.). "St John's wort for major depression". Cochrane Database Syst Rev. 2008 (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMC 7032678. PMID 18843608.
Apaydin EA, Maher AR, Shanman R, et al. (2016). "A systematic review of St. John's wort for major depressive disorder". Syst Rev. 5 (1): 148. doi:10.1186/s13643-016-0325-2. PMC 5010734. PMID 27589952.
Ng QX, Venkatanarayanan N, Ho CY (March 2017). "Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis". Journal of Affective Disorders. 210: 211–221. doi:10.1016/j.jad.2016.12.048. PMID 28064110.
Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE (2020). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. ISSN 0007-1188. PMC 7056460. PMID 31742659.
Komoroski BJ, Zhang S, Cai H, Hutzler JM, et al. (2004). "Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures". Drug Metabolism and Disposition: The Biological Fate of Chemicals. 32 (5): 512–518. doi:10.1124/dmd.32.5.512. ISSN 0090-9556. PMID 15100173.
Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ (9 December 2018). "Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content". Journal of Pharmacy and Pharmacology. 71 (1): 129–138. doi:10.1111/jphp.12858. ISSN 2042-7158. PMID 29411879. S2CID 46807341.
Nicolussi S, Drewe J, Butterweck V, Meyer H (19 November 2019). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. PMC 7056460. PMID 31742659.

dx.doi.org

Linné C, Salvius L (1753). Species plantarum. Holmiae: Impensis Laurentii Salvii. p. 785. doi:10.5962/bhl.title.669.

gbif.org

Registry-Migration.Gbif.Org (2022). "Hypericum perforatum L." GBIF Secretariat. Global Biodiversity Information Facility. doi:10.15468/39omei. Retrieved 1 August 2023.

harvard.edu

ui.adsabs.harvard.edu

Tatsis EC, Boeren S, Exarchou V, Troganis AN, Vervoort J, Gerothanassis IP (2007). "Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS". Phytochemistry. 68 (3): 383–93. Bibcode:2007PChem..68..383T. doi:10.1016/j.phytochem.2006.11.026. PMID 17196625. S2CID 28120366.

invasive.org

"SPECIES: Hypericum perforatum" (PDF). Fire Effects Information System.

jstor.org

Marcone C, Bellardi M, Bertaccini A (2016). "Phytoplasma diseases of medicinal and aromatic plants". Journal of Plant Pathology. 98 (3): 379–404. doi:10.4454/JPP.V98I3.060. JSTOR 44280481.

kew.org

powo.science.kew.org

"Hypericum perforatum L." Plants of the World Online. Royal Botanic Gardens, Kew. Retrieved 1 August 2023.

missouribotanicalgarden.org

"Hypericum perforatum". Plant Finder. St. Louis, Missouri: Missouri Botanical Garden. Retrieved 1 August 2023.

mskcc.org

"St. John's Wort". Memorial Sloan Kettering Cancer Center. 2022. Archived from the original on 21 June 2024.

naturalstandard.com

"St. John's wort". Natural Standard. Cambridge, MA. Retrieved 13 December 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Soelberg J, Jorgensen LB, Jager AK (26 January 2007). "Hyperforin Accumulates in the Translucent Glands of Hypericum perforatum". Annals of Botany. 99 (6): 1097–1100. doi:10.1093/aob/mcm057. PMC 3243575. PMID 17468113.
Zobayed SM, Afreen F, Goto E, Kozai T (1 October 2006). "Plant–Environment Interactions: Accumulation of Hypericin in Dark Glands of Hypericum perforatum". Annals of Botany. 98 (4): 793–804. doi:10.1093/aob/mcl169. PMC 2806163. PMID 16891333.
Umek A, Kreft S, Kartnig T, Heydel B (1999). "Quantitative phytochemical analyses of six hypericum species growing in slovenia". Planta Med. 65 (4): 388–90. doi:10.1055/s-2006-960798. PMID 17260265. S2CID 260248637.
Tatsis EC, Boeren S, Exarchou V, Troganis AN, Vervoort J, Gerothanassis IP (2007). "Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS". Phytochemistry. 68 (3): 383–93. Bibcode:2007PChem..68..383T. doi:10.1016/j.phytochem.2006.11.026. PMID 17196625. S2CID 28120366.
Süntar IP, Akkol EK, Yılmazer D, et al. (2010). "Investigations on the in vivo wound healing potential of Hypericum perforatum L.". Journal of Ethnopharmacology. 127 (2): 468–77. doi:10.1016/j.jep.2009.10.011. PMID 19833187.
Gaid M, Biedermann E, Füller J, et al. (1 May 2018). "Biotechnological production of hyperforin for pharmaceutical formulation". European Journal of Pharmaceutics and Biopharmaceutics. Innovative Processes for Bio-Pharmaceuticals and Poorly Water-Soluble API. 126: 10–26. doi:10.1016/j.ejpb.2017.03.024. ISSN 0939-6411. PMID 28377273. S2CID 4701643.
Linde K, Kriston L, Rücker G, Jamila S, Schumann I, Meissner K, Sigterman K, Schneider A (February 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Annals of Family Medicine. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895.
Linde K, Berner MM, Kriston L (2008). Linde K (ed.). "St John's wort for major depression". Cochrane Database Syst Rev. 2008 (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMC 7032678. PMID 18843608.
Apaydin EA, Maher AR, Shanman R, et al. (2016). "A systematic review of St. John's wort for major depressive disorder". Syst Rev. 5 (1): 148. doi:10.1186/s13643-016-0325-2. PMC 5010734. PMID 27589952.
Ng QX, Venkatanarayanan N, Ho CY (March 2017). "Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis". Journal of Affective Disorders. 210: 211–221. doi:10.1016/j.jad.2016.12.048. PMID 28064110.
Peterson B, Nguyen H (2023), "St John's Wort", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491397, retrieved 4 August 2023
Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE (2020). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. ISSN 0007-1188. PMC 7056460. PMID 31742659.
Komoroski BJ, Zhang S, Cai H, Hutzler JM, et al. (2004). "Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures". Drug Metabolism and Disposition: The Biological Fate of Chemicals. 32 (5): 512–518. doi:10.1124/dmd.32.5.512. ISSN 0090-9556. PMID 15100173.
Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ (9 December 2018). "Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content". Journal of Pharmacy and Pharmacology. 71 (1): 129–138. doi:10.1111/jphp.12858. ISSN 2042-7158. PMID 29411879. S2CID 46807341.
Nicolussi S, Drewe J, Butterweck V, Meyer H (19 November 2019). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. PMC 7056460. PMID 31742659.

ncbi.nlm.nih.gov

Soelberg J, Jorgensen LB, Jager AK (26 January 2007). "Hyperforin Accumulates in the Translucent Glands of Hypericum perforatum". Annals of Botany. 99 (6): 1097–1100. doi:10.1093/aob/mcm057. PMC 3243575. PMID 17468113.
Zobayed SM, Afreen F, Goto E, Kozai T (1 October 2006). "Plant–Environment Interactions: Accumulation of Hypericin in Dark Glands of Hypericum perforatum". Annals of Botany. 98 (4): 793–804. doi:10.1093/aob/mcl169. PMC 2806163. PMID 16891333.
Linde K, Kriston L, Rücker G, Jamila S, Schumann I, Meissner K, Sigterman K, Schneider A (February 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Annals of Family Medicine. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895.
Linde K, Berner MM, Kriston L (2008). Linde K (ed.). "St John's wort for major depression". Cochrane Database Syst Rev. 2008 (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMC 7032678. PMID 18843608.
Apaydin EA, Maher AR, Shanman R, et al. (2016). "A systematic review of St. John's wort for major depressive disorder". Syst Rev. 5 (1): 148. doi:10.1186/s13643-016-0325-2. PMC 5010734. PMID 27589952.
Peterson B, Nguyen H (2023), "St John's Wort", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491397, retrieved 4 August 2023
Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE (2020). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. ISSN 0007-1188. PMC 7056460. PMID 31742659.
Nicolussi S, Drewe J, Butterweck V, Meyer H (19 November 2019). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. PMC 7056460. PMID 31742659.

nccih.nih.gov

"St. John's Wort". National Center for Complementary and Integrative Health, US National Institutes of Health. October 2020. Retrieved 3 September 2023.

northwestweeds.com.au

"St John's wort – Hypericum perforatum". North West Weeds. Archived from the original on 31 March 2016. Retrieved 19 October 2015.

nrm.se

www2.nrm.se

"Agonopterix hypericella (Insecta: Lepidoptera: Depressariidae)". Svenska Fjärilar. Naturhistoriska Riksmuseet. Retrieved 10 August 2023.

oup.com

academic.oup.com

Ciccarelli D (October 2001). "Translucent Glands and Secretory Canals in Hypericum perforatum L. (Hypericaceae): Morphological, Anatomical and Histochemical Studies During the Course of Ontogenesis" (PDF). Annals of Botany. 88 (4): 637–644. doi:10.1006/ANBO.2001.1514. Retrieved 28 July 2023.

ouryao.com

db.ouryao.com

"舒肝解郁胶囊 – 中国药典、药品标准、法规在线查询" [Shugan Jieyu Capsules – Chinese Pharmacopoeia, drug standards and regulations]. db.ouryao.com (in Chinese). 2020. Retrieved 26 November 2022.

pharmaxchange.info

Mehta S (18 December 2012). "Pharmacognosy of St. John's Wort". Pharmaxchange.info. Retrieved 16 February 2014.

pollenatlas.net

"Hypericum perforatum". Pollen Atlas. Retrieved 27 September 2023.

sciencedirect.com

Mayor A (1 January 2019), Wexler P (ed.), "Chapter 11 – Mithridates of Pontus and His Universal Antidote", Toxicology in Antiquity (Second Edition), History of Toxicology and Environmental Health, Academic Press, pp. 161–174, doi:10.1016/b978-0-12-815339-0.00011-1, ISBN 978-0-12-815339-0, retrieved 27 September 2023
Karamanou M, Androutsos G (1 January 2019), Wexler P (ed.), "Chapter 12 - Theriaca Magna: The Glorious Cure-All Remedy", Toxicology in Antiquity (Second Edition), History of Toxicology and Environmental Health, Academic Press, pp. 175–184, doi:10.1016/b978-0-12-815339-0.00012-3, ISBN 978-0-12-815339-0, retrieved 27 September 2023
Gaid M, Biedermann E, Füller J, et al. (1 May 2018). "Biotechnological production of hyperforin for pharmaceutical formulation". European Journal of Pharmaceutics and Biopharmaceutics. Innovative Processes for Bio-Pharmaceuticals and Poorly Water-Soluble API. 126: 10–26. doi:10.1016/j.ejpb.2017.03.024. ISSN 0939-6411. PMID 28377273. S2CID 4701643.

semanticscholar.org

api.semanticscholar.org

Umek A, Kreft S, Kartnig T, Heydel B (1999). "Quantitative phytochemical analyses of six hypericum species growing in slovenia". Planta Med. 65 (4): 388–90. doi:10.1055/s-2006-960798. PMID 17260265. S2CID 260248637.
Tatsis EC, Boeren S, Exarchou V, Troganis AN, Vervoort J, Gerothanassis IP (2007). "Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS". Phytochemistry. 68 (3): 383–93. Bibcode:2007PChem..68..383T. doi:10.1016/j.phytochem.2006.11.026. PMID 17196625. S2CID 28120366.
Gaid M, Biedermann E, Füller J, et al. (1 May 2018). "Biotechnological production of hyperforin for pharmaceutical formulation". European Journal of Pharmaceutics and Biopharmaceutics. Innovative Processes for Bio-Pharmaceuticals and Poorly Water-Soluble API. 126: 10–26. doi:10.1016/j.ejpb.2017.03.024. ISSN 0939-6411. PMID 28377273. S2CID 4701643.
Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ (9 December 2018). "Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content". Journal of Pharmacy and Pharmacology. 71 (1): 129–138. doi:10.1111/jphp.12858. ISSN 2042-7158. PMID 29411879. S2CID 46807341.

usda.gov

plants.sc.egov.usda.gov

NRCS (1 August 2023), "Hypericum perforatum", PLANTS Database, United States Department of Agriculture (USDA)

wa.gov

nwcb.wa.gov

Protect Your Horses and Livestock From Toxic Plants (PDF). Washington State Noxious Weed Control Board. 2017. p. 49.

web.archive.org

Barnes, J., Anderson, L.A., Phillipson, J.D. (2007) [1996]. Herbal Medicines (PDF) (3rd ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85369-623-0. Archived from the original (PDF) on 1 July 2018. Retrieved 7 February 2015.
"bladmineerders.nl". bladmineerders.nl. Archived from the original on 4 March 2016. Retrieved 18 January 2019.
"St John's wort – Hypericum perforatum". North West Weeds. Archived from the original on 31 March 2016. Retrieved 19 October 2015.
"St John's wort and cancer". Cancer Research UK. 2022. Archived from the original on 12 June 2024.
"Complementary therapies". Cancer Council Victoria. 2024. Archived from the original on 3 October 2024.
"Questions and Answers About St. John's Wort". National Cancer Institute. 2024. Archived from the original on 2 October 2024.
"St. John's Wort". Memorial Sloan Kettering Cancer Center. 2022. Archived from the original on 21 June 2024.

worldcat.org

search.worldcat.org

Gaid M, Biedermann E, Füller J, et al. (1 May 2018). "Biotechnological production of hyperforin for pharmaceutical formulation". European Journal of Pharmaceutics and Biopharmaceutics. Innovative Processes for Bio-Pharmaceuticals and Poorly Water-Soluble API. 126: 10–26. doi:10.1016/j.ejpb.2017.03.024. ISSN 0939-6411. PMID 28377273. S2CID 4701643.
Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE (2020). "Clinical relevance of St. John's wort drug interactions revisited". British Journal of Pharmacology. 177 (6): 1212–1226. doi:10.1111/bph.14936. ISSN 0007-1188. PMC 7056460. PMID 31742659.
Komoroski BJ, Zhang S, Cai H, Hutzler JM, et al. (2004). "Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures". Drug Metabolism and Disposition: The Biological Fate of Chemicals. 32 (5): 512–518. doi:10.1124/dmd.32.5.512. ISSN 0090-9556. PMID 15100173.
Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ (9 December 2018). "Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content". Journal of Pharmacy and Pharmacology. 71 (1): 129–138. doi:10.1111/jphp.12858. ISSN 2042-7158. PMID 29411879. S2CID 46807341.

zums.ac.ir

file.zums.ac.ir

Barnes, J., Anderson, L.A., Phillipson, J.D. (2007) [1996]. Herbal Medicines (PDF) (3rd ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85369-623-0. Archived from the original (PDF) on 1 July 2018. Retrieved 7 February 2015.